BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chang CS, Yan SL, Lin HY, Yu FL, Tsai CY. Pure red cell aplasia caused by pegylated interferon-α-2a plus ribavirin in the treatment of chronic hepatitis C. World J Gastroenterol 2011; 17(16): 2155-2158 [PMID: 21547138 DOI: 10.3748/wjg.v17.i16.2155]
URL: https://www.wjgnet.com/1007-9327/full/v17/i16/2155.htm
Number Citing Articles
1
Naba R Mainali, Vijaya R Bhatt, Shiksha Kedia, Jairam Krishnamurthy, Laura M Wake, Mojtaba Akhtari. Reversible bone marrow aplasia induced by pegylated interferon-α-2a therapy in a patient with primary myelofibrosisJournal of Oncology Pharmacy Practice 2014; 20(5): 386 doi: 10.1177/1078155213504444
2
Scott C Quinlan, Jennifer C.L Hawes, Daniel Mines, Shirin Ahmed, Stephan Lanes, Vinay Mehta, Crystal N Holick, Nancy Santanello, T Christopher Mast. Performance of an administrative claims algorithm to estimate the incidence of pure red cell aplasia in chronic hepatitis C patientsEpidemiology Reports 2015; 3(1): 1 doi: 10.7243/2054-9911-3-1
3
Keiji Hirai, Susumu Ookawara, Haruhisa Miyazawa, Kiyonori Ito, Yuichiro Ueda, Yoshio Kaku, Taro Hoshino, Shun-ichi Kimura, Izumi Yoshida, Sachiko Kakuta, Yoshiyuki Morishita, Kaoru Tabei. Successful treatment of a hemodialyzed patient with pure red cell aplasia associated with epoetin beta pegol therapy with cyclosporineCEN Case Reports 2016; 5(1): 78 doi: 10.1007/s13730-015-0196-8
4
Meyler's Side Effects of Drugs2016; : 115 doi: 10.1016/B978-0-444-53717-1.01403-7
5
Gwen Masclee, Jeffrey K. Aronson. A worldwide yearly survey of new data in adverse drug reactions and interactionsSide Effects of Drugs Annual 2014; 35: 659 doi: 10.1016/B978-0-444-62635-6.00037-1
6
Jian-Wu Yu, Li-Jie Sun, Yong-Hua Zhao, Peng Kang, Bing-Zhu Yan. The study of relationship between neutropenia and infection during treatment with peginterferon α and ribavirin for chronic hepatitis CEuropean Journal of Gastroenterology & Hepatology 2011; 23(12): 1192 doi: 10.1097/MEG.0b013e32834c5b32
7
I.D. Ramsay, J.M. Lestner, C.I.S. Barker. A worldwide yearly survey of new data in adverse drug reactions and interactionsSide Effects of Drugs Annual 2014; 35: 503 doi: 10.1016/B978-0-444-62635-6.00029-2
8
Chenue Abongwa, Ghada Abusin, Ayman El-Sheikh. Successful treatment of tacrolimus-related pure red cell aplasia and autoimmune hemolytic anemia with rituximab in a pediatric cardiac transplant patientPediatric Blood & Cancer 2017; 64(12): e26674 doi: 10.1002/pbc.26674
9
Javier Ampuero, José Antonio Del Campo, Lourdes Rojas, José Luis Calleja, Joaquín Cabezas, Sabela Lens, Javier Crespo, Xavier Forns, Raúl J. Andrade, Inmaculada Fernández, María Buti, Raquel Millán, Manuel Romero-Gómez. Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatmentJournal of Clinical Virology 2015; 68: 56 doi: 10.1016/j.jcv.2015.05.010
10
Annie K. Hung, Jennifer Guy, Caroline M. Behler, Eugene E. Lee. Anti-Erythropoietin Antibody Associated Pure Red Cell Aplasia Resolved after Liver TransplantationCase Reports in Transplantation 2015; 2015: 1 doi: 10.1155/2015/286276
11
Brian A. Baldo. Side Effects of Cytokines Approved for TherapyDrug Safety 2014; 37(11): 921 doi: 10.1007/s40264-014-0226-z